Company Focus
Merck KGaA
Latest Merck KGaA News
Pharmaceutical
The upcoming European Society for Medical Oncology (ESMO) Congress 2024 should provide a reminder—if it were needed—of the pace of innovation in the development of new medicines for cancer. 10 September 2024
Related News
Insights
Company Spotlight
A clinical-stage biotech company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders.
Latest News & Features of interest to Merck KGaA
Pharmaceutical
Chugai Pharmaceutical says its Taiwan subsidiary (CPT) has obtained an import drug license from the Taiwan Food and Drug Administration (TFDA) for Alecensa (alectinib) 2 August 2024
Biotechnology
Change in on the way at California’s Vir Biotechnology. 2 August 2024
Pharmaceutical
BridGene Biosciences is expanding its collaboration with Belgian firm Galapagos (Euronext: GLPG) to advance drug discovery for challenging cancer targets. 2 August 2024
Biotechnology
The US Food and Drug Administration (FDA) yesterday approved Jemperli (dostarlimab-gxly), from UK pharm major GSK. 2 August 2024
Biotechnology
Seattle, USA-based cell therapy company Outpace Bio says it has raised $144 million in an oversubscribed Series B financing. 2 August 2024
Biotechnology
US biotech Regeneron Pharmaceuticals today announced financial results for the second quarter of 2024 that beat expectations. 1 August 2024
Biotechnology
A change at the top is on the way at Cour Pharmaceuticals, a privately-held US biotech developing disease-modifying therapies designed to induce antigen-specific tolerance for immune-mediated diseases. 1 August 2024
Biotechnology
Japanese drugmaker Otsuka Pharmaceuticals is to buy privately-held US biotech Jnana Therapeutics. 1 August 2024
Pharmaceutical
Eli Lilly released positive top-line results from the SUMMIT Phase III clinical trial evaluating the safety and efficacy of tirzepatide injection in adults with heart failure with preserved ejection fraction (HFpEF) and obesity. 1 August 2024
Biotechnology
US biotech Biogen reported its second-quarter financial results and published its latest guidance on Thursday. 1 August 2024
Latest In Brief for Merck KGaA
Biotechnology
Oxford, UK-based Enara Bio today announces the closing of a $32.5 million Series B financing supported by a strong syndicate of new and existing biotech investors. 3 October 2024
Latest Relevant Ones To Watch News
US clinical-stage biotech OnKure Therapeutics has announced the completion of its previously announced merger with Reneo Pharmaceuticals. 8 October 2024
24 September 2024
9 September 2024
5 September 2024
Relevant Ones to Watch Companies
Refine Search
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze